Anti-human IL23A scFv Fragment (Risankizumab)
Recombinant monoclonal antibody Risankizumab is a humanized monoclonal antibody that specifically binds to human IL-23A and can be potentially used in the treatment of Crohn's disease, psoriasis, psoriatic arthritis and asthma.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-620LC-S(P) |
| Pricing | Inquiry |
| Type | Humanized antibody |
| Applications | ELISA |
| Host | Human |
| Target | IL-23A (Interleukin 23 p19 subunit) |